Curing Mosquitoes, Eliminating Malaria
A new study authored by UF Emerging Pathogens Institute (EPI) researcher Rhoel Dinglasan, Ph.D., and colleagues, twists the narrative in the fight... Read More
Study Helps Hepatitis C Patients, Shows Path for Accelerating Research and Potential for Drug Approvals
In a new kind of real-world study, a “pragmatic” clinical trial, UF researchers found that hepatitis C patients who previously did not... Read More
SharpSpring Announces Acquisition of Perfect Audience From Marin Software
UF startup SharpSpring, Inc., a leading cloud-based marketing automation platform for digital marketing agencies, announced it has acquired the digital advertising platform... Read More
Exactech Acquires Italian Distributor
UF startup Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery, announced that it acquired... Read More
$6 Million Expansion for Gene Therapy Facility Completed at Alachua’s Progress Park
Local and state officials gathered in Alachua to commemorate a $6 million expansion at Progress Park. Representatives of Thermo Fisher Scientific Inc.,... Read More
DNAtrix Presents Positive Results From Study at the 2019 SNO Annual Meeting
UF startup DNAtrix, a leader in the development of oncolytic viruses for cancer therapy, presented updated safety and efficacy data from the fully-enrolled... Read More
Algernon Pharmaceuticals Provides Update on Its Planned Phase II Clinical Trial
UF startup Algernon Pharmaceuticals Inc., formerly known as Breathtec Biomedical, a clinical-stage pharmaceutical development company, provided an update to the market on... Read More
Unlocking Chlamydia’s Persistent State
New research from the Emerging Pathogens Institute (EPI) and UF’s College of Public Health & Health Professions found that exposing the sexually-transmitted... Read More
Immunomic Therapeutics’ Collaborator, a University of Florida Researcher, Presents New Clinical Data at the 2019 Society for Neuro-Oncology (SNO) Annual Meeting
Immunomic Therapeutics, Inc., a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced that Duane Mitchell, MD, Ph.D.,... Read More
Have Hope: Discover Treatment Options for Pancreatic Cancer
Pancreatic cancer affects more than 42,000 Americans each year and is the fourth leading cause of cancer-related death in the United States.... Read More
